Evidence map›Paper›PMID 29905769›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts-Abu Dhabi, United Arab Emirates.

Farida Ismail Al Hosani, Lindsay Kim, Ahmed Khudhair, Huong Pham, Mariam Al Mulla, Zyad Al Bandar, Krishna Pradeep, Kheir Abou Elkheir, Stefan Weber, Mary Khoury and 19 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Budget Impact of Microbial Cell-Free DNA Testing Using the KariusApplied health economics and health policy · 2021
    Article
  9. Budget Impact of Microbial Cell-Free DNA Testing Using the KariusApplied health economics and health policy · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Household Secondary Attack Rate of COVID-19 and Associated Determinants.medRxiv : the preprint server for health sciences · 2020
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Farida Ismail Al HosaniDepartment of Health-Abu Dhabi, United Arab Emirates.
Lindsay KimDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Ahmed KhudhairDepartment of Health-Abu Dhabi, United Arab Emirates.
Huong PhamDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Mariam Al MullaDepartment of Health-Abu Dhabi, United Arab Emirates.
Zyad Al BandarDepartment of Health-Abu Dhabi, United Arab Emirates.
Krishna PradeepDepartment of Health-Abu Dhabi, United Arab Emirates.
Kheir Abou ElkheirDepartment of Health-Abu Dhabi, United Arab Emirates.
Stefan WeberSheikh Khalifa Medical Laboratory, Abu Dhabi, United Arab Emirates.
Mary KhourySheikh Khalifa Medical Laboratory, Abu Dhabi, United Arab Emirates.
George DonnellySheikh Khalifa Medical Laboratory, Abu Dhabi, United Arab Emirates.
Naima YounisDepartment of Health-Abu Dhabi, United Arab Emirates.
Feda El SalehDepartment of Health-Abu Dhabi, United Arab Emirates.
Muna AbdallaDepartment of Health-Abu Dhabi, United Arab Emirates.
Hala ImambaccusSheikh Khalifa Medical Laboratory, Abu Dhabi, United Arab Emirates.
Lia M HaynesDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Natalie J ThornburgDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Jennifer L HarcourtDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Congrong MiaoDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Azaibi TaminDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Aron J HallDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Elizabeth S RussellEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
Aaron M HarrisUnited States Public Health Service, Rockville, Maryland.
Craig KieblerEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
Roger A MirDivision of Health Informatics and Surveillance, Centers for Disease Control and Prevention, Atlanta, Georgia.
Kimberly PringleDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Negar N AlamiEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
Glen R AbediDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Susan I GerberDivision of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although there is evidence of person-to-person transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in household and healthcare settings, more data are needed to describe and better understand the risk factors and transmission routes in both settings, as well as the extent to which disease severity affects transmission. Methods: A seroepidemiological investigation was conducted among MERS-CoV case patients (cases) and their household contacts to investigate transmission risk in Abu Dhabi, United Arab Emirates. Cases diagnosed between 1 January 2013 and 9 May 2014 and their household contacts were approached for enrollment. Demographic, clinical, and exposure history data were collected. Sera were screened by MERS-CoV nucleocapsid protein enzyme-linked immunosorbent assay and indirect immunofluorescence, with results confirmed by microneutralization assay. Results: Thirty-one of 34 (91%) case patients were asymptomatic or mildly symptomatic and did not require oxygen during hospitalization. MERS-CoV antibodies were detected in 13 of 24 (54%) case patients with available sera, including 1 severely symptomatic, 9 mildly symptomatic, and 3 asymptomatic case patients. No serologic evidence of MERS-CoV transmission was found among 105 household contacts with available sera. Conclusions: Transmission of MERS-CoV was not documented in this investigation of mostly asymptomatic and mildly symptomatic cases and their household contacts. These results have implications for clinical management of cases and formulation of isolation policies to reduce the risk of transmission.

Indexed as

Disease Transmission, InfectiousAdolescentAdultAgedAged, 80 and overAntibodies, ViralChildChild, PreschoolCoronavirus InfectionsEnzyme-Linked Immunosorbent AssayFamily HealthFemaleFluorescent Antibody Technique, IndirectHumansInfantInfant, NewbornAntibodies, Viral

Identifiers

PMID29905769
PMCPMC7108211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.